Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zotepine vs Risperidone in Aggressive Schizophrenia
NCT00418873Phase 4Terminated
- Sponsor
- Astellas Pharma
- Start
- Mar 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zotepine in schizophrenia (2 arms), sponsored by Astellas Pharma. Primary endpoint: Change from baseline in Positive and Negative Syndrome Scale Excited Component at 6 weeks. Started Mar 2007; status: terminated.
02
Drugs
zotepine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00418873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418873.